Greater Manchester Medicines Management Group

images courtesy of NHS Photo Library

NHS logo

GMMMG Consultations

 

On this page you will find proposed changes that are currently going through the GMMMG approval process. This will include consultations on proposed RAG status, updated Formulary Chapters, Pathways or other GMMMG Guidance. You will be able to comment on current proposals via the links in the table below.

Due to the COVID-19 outbreak all active GMMMG consultations were temporarily suspended in April. The active consultations have now been re-opened; please see below for the new end dates. Every effort has been made to allow sufficient time for appropriate clinical input to these documents, but if you foresee any problems or have any questions please email nuth.enquires.gmmmg@nhs.net

Title

Information

Feedback

End date

102

GMMMG Indigo Transgender Service Shared Care Protocols
zipped file

On behalf of the GMMMG Clinical Reference Group, we now seek comments on a series of draft shared care protocols to support the safe transfer of prescribing between Indigo Gender Services and GM primary care prescribers. This consultation contains three SCPs, one for each of; oestrogens, testosterone, and gonadotrophin-releasing hormones (GnRH) analogues, and uses the new GMMMG SCP template.
Please submit comments before 5pm Tuesday 16th February 2021

Feedback Form

5pm Tuesday
16th February 2021

101

GMMMG Clinical Reference Group- actions proposed at December’s meeting

On behalf of the GMMMG Clinical Reference Group, we now seek comments on actions proposed at the December meeting. This consultation period is open until 5pm Monday 15th February 2021

Feedback Form

5pm Monday
15th February 2021

100

GMMMG COPD Management Plan

The Greater Manchester-Wide COPD Pathway Development Group is pleased to present an updated version of the GMMMG COPD Management Plan. This revised version is still based on GOLD guidance and has a greater emphasis on low carbon options, as well as further detail for certain topics. Please submit comments by Friday 15th January 2021. The RDTC® is developing a tool which will be made available to CCG Medicines Optimisation teams in the coming weeks to consider the carbon dioxide equivalent values (a standard unit for measuring carbon footprint) alongside the financial impact posed by the different inhaler options. This will enable local teams to identify affordable improvements in their carbon footprint through appropriate inhaler choice based on their current usage and with consideration to the principle of this management plan.

Feedback Form

5pm Friday
15th January 2021

99

GMMMG Clinical Reference Group- actions proposed at November’s meeting
[Link removed - consultation closed]

On behalf of the GMMMG Clinical Reference Group, we now seek comments [Link removed - consultation closed] on actions [Link removed - consultation closed] proposed at the November meeting. This consultation period is open until 5pm Thursday 31st December 2020.

Feedback Form
[Link removed - consultation closed]

5pm Thursday
31st December 2020

<< Back

Line

TERMS AND CONDITIONS    |    CONTACT US    |    ABOUT US    |    ARCHIVE

RSS Feed
 
spacer